InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,132.39
(
0.88%
)
Post# of 251939
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119690
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 202169

Wednesday, 08/03/2016 4:10:17 PM

Wednesday, August 03, 2016 4:10:17 PM

Post# of 251939
OCRX has enrolled 195 of 230 patients in STOP-HE and expects to complete enrollment in 4Q16:

http://finance.yahoo.com/news/ocera-therapeutics-reports-second-quarter-200500105.html

The 195 number is up from 180 six weeks ago (#msg-123459268) implying an enrollment rate of about 2.5 patients per week. If the enrollment rate stays at this level, it will take until mid-November to hit 230, meeting the 4Q16 guidance above.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up